Pharmaceuticals: Spain Industry Guide is an essential resource for top-level data and analysis covering the Spain Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis with distinct chapters for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals.
Scope of the Report
* Contains an executive summary and data on value, volume and segmentation for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals
* Provides textual analysis of the industry’s prospects, competitive landscape and profiles of the leading companies
* Incorporates in-depth five forces competitive environment analysis and scorecards
* Includes five-year forecasts for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals
Highlights
* The Spanish biotechnology market grew by 7.1% in 2007 to reach a value of $7,341 million.
* The Spanish generics market generated total revenues of $1.2 billion in 2007, representing a compound annual growth rate (CAGR) of 15.8% for the period spanning 2003-2007.
* The Spanish OTC pharmaceuticals market generated total revenues of $1.9 billion in 2008, representing a compound annual growth rate (CAGR) of 3% for the period spanning 2004-2008.
* The Spanish pharmaceutical market generated total revenues of $18 billion in 2008, representing a compound annual growth rate (CAGR) of 5.5% for the period spanning 2004-2008.
Why you should buy this report
* Spot future trends and developments
* Inform your business decisions
* Add weight to presentations and marketing materials
* Save time carrying out entry-level research
CHAPTER 1 BIOTECHNOLOGY IN SPAIN 10
1.1 Market Overview 10
1.2 Market Value 12
1.3 Market Segmentation I 13
1.4 Market Segmentation II 15
1.5 Five Forces Analysis 16
1.6 Market Forecasts 22
CHAPTER 2 GENERICS IN SPAIN 23
2.1 Market Overview 23
2.2 Market Value 25
2.3 Market Segmentation I 26
2.4 Market Segmentation II 27
2.5 Five Forces Analysis 28
2.6 Market Forecasts 35
CHAPTER 3 OTC PHARMACEUTICALS IN SPAIN 36
3.1 Market Overview 36
3.2 Market Value 38
3.3 Market Segmentation I 39
3.4 Market Segmentation II 40
3.5 Market Share 41
3.6 Five Forces Analysis 42
3.7 Distribution 48
3.8 Market Forecasts 49
CHAPTER 4 PHARMACEUTICALS IN SPAIN 50
4.1 Market Overview 50
4.2 Market Value 52
4.3 Market Segmentation I 53
4.4 Market Segmentation II 54
4.5 Market Share 55
4.6 Five Forces Analysis 56
4.7 Market Forecasts 64
CHAPTER 5 DEMOGRAPHICS 65
CHAPTER 6 APPENDIX 67
6.1 Data Research Methodology 67
LIST OF TABLES
Table 1: Spain Biotechnology Market Value: $ million, 2003-2007 12
Table 2: Spain Biotechnology Market Segmentation I: % Share, by Value, 2007 13
Table 3: Spain Biotechnology Market Segmentation II: % Share, by Value, 2007 15
Table 4: Spain Biotechnology Market Value Forecast: $ million, 2007-2012 22
Table 5: Spain Generics Market Value: $ billion, 2003-2007 25
Table 6: Spain Generics Market Segmentation I: % Share, by Value, 2007 26
Table 7: Spain Generics Market Segmentation II: % Share, by Value, 2007 27
Table 8: Spain Generics Market Value Forecast: $ billion, 2007-2012 35
Table 9: Spain OTC Pharmaceuticals Market Value: $ billion, 2004-2008(e) 38
Table 10: Spain OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e) 39
Table 11: Spain OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e) 40
Table 12: Spain OTC Pharmaceuticals Market Share: % Share, by Value, 2007 41
Table 13: Spain OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e) 48
Table 14: Spain OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 49
Table 15: Spain Pharmaceuticals Market Value: $ million, 2003-2007 52
Table 16: Spain Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 53
Table 17: Spain Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 54
Table 18: Spain Pharmaceuticals Market Share: % Share, by Value, 2007 55
Table 19: Spain Pharmaceuticals Market Value Forecast: $ million, 2007-2012 64
Table 20: Spain Size of Population (million) , 2003-2007 65
Table 21: Spain GDP (Constant 2000 Prices, $ billion), 2003-2007 65
Table 22: Spain Inflation, 2003-2007 65
Table 23: Spain Exchange Rate, 2003 66
LIST OF FIGURES
Figure 1: Spain Biotechnology Market Value: $ million, 2003-2007 12
Figure 2: Spain Biotechnology Market Segmentation I: % Share, by Value, 2007 13
Figure 3: Spain Biotechnology Market Segmentation II: % Share, by Value, 2007 15
Figure 4: Forces Driving Competition in the Biotechnology Market in Spain, 2007 16
Figure 5: Drivers of Buyer Power in the Biotechnology Market in Spain, 2007 17
Figure 6: Drivers of Supplier Power in the Biotechnology Market in Spain, 2007 18
Figure 7: Factors Influencing the Likelihood of New Entrants in the Biotechnology Market in Spain, 2007 19
Figure 8: Factors Influencing the Threat of Substitutes in the Biotechnology Market in Spain, 2007 20
Figure 9: Drivers of Degree of Rivalry in the Biotechnology Market in Spain, 2007 21
Figure 10: Spain Biotechnology Market Value Forecast: $ million, 2007-2012 22
Figure 11: Spain Generics Market Value: $ billion, 2003-2007 25
Figure 12: Spain Generics Market Segmentation I: % Share, by Value, 2007 26
Figure 13: Spain Generics Market Segmentation II: % Share, by Value, 2007 27
Figure 14: Forces Driving Competition in the Generics Market in Spain, 2007 28
Figure 15: Drivers of Buyer Power in the Generics Market in Spain, 2007 30
Figure 16: Drivers of Supplier Power in the Generics Market in Spain, 2007 31
Figure 17: Factors Influencing the Likelihood of New Entrants in the Generics Market in Spain, 2007 32
Figure 18: Factors Influencing the Threat of Substitutes in the Generics Market in Spain, 2007 33
Figure 19: Drivers of Degree of Rivalry in the Generics Market in Spain, 2007 34
Figure 20: Spain Generics Market Value Forecast: $ billion, 2007-2012 35
Figure 21: Spain OTC Pharmaceuticals Market Value: $ billion, 2004-2008(e) 38
Figure 22: Spain OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e) 39
Figure 23: Spain OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e) 40
Figure 24: Spain OTC Pharmaceuticals Market Share: % Share, by Value, 2007 41
Figure 25: Forces Driving Competition in the OTC Pharmaceuticals Market in Spain 42
Figure 26: Drivers of Buyer Power in the OTC Pharmaceuticals Market in Spain 43
Figure 27: Drivers of Supplier Power in the OTC Pharmaceuticals Market in Spain 44
Figure 28: Factors Influencing the Likelihood of New Entrants in the OTC Pharmaceuticals Market in Spain 45
Figure 29: Factors Influencing the Threat of Substitutes in the OTC Pharmaceuticals Market in Spain 46
Figure 30: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market in Spain 47
Figure 31: Spain OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e) 48
Figure 32: Spain OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 49
Figure 33: Spain Pharmaceuticals Market Value: $ million, 2003-2007 52
Figure 34: Spain Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 53
Figure 35: Spain Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 54
Figure 36: Spain Pharmaceuticals Market Share: % Share, by Value, 2007 55
Figure 37: Forces Driving Competition in the Pharmaceuticals Market in Spain, 2007 56
Figure 38: Drivers of Buyer Power in the Pharmaceuticals Market in Spain, 2007 58
Figure 39: Drivers of Supplier Power in the Pharmaceuticals Market in Spain, 2007 59
Figure 40: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in Spain, 2007 60
Figure 41: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in Spain, 2007 62
Figure 42: Drivers of Degree of Rivalry in the Pharmaceuticals Market in Spain, 2007 63
Figure 43: Spain Pharmaceuticals Market Value Forecast: $ million, 2007-2012 64
Other selected research from the 'Spain' category:
The eHealth Market in Italy and Spain: Maximizing Consumer Channels of Influence
Personal Hygiene/ Personal Care: Spain Industry Guide
Other selected research from the 'Markets' category:
World Sleep Disorders Market Analysis 2009-2024
Commercial Insight: Antihypertensives - Can Manufacturers Maintain Value?